Results 91 to 100 of about 222 (145)
Repolarization adaptation to rapid change in heart rate in human models – a review
Abstract figure legend This review focuses on non‐invasive assessment of repolarization duration and dispersion (heterogeneity) adaptation to change in heart rate (HR). HR was increased incrementally by left atrial pacing during an electrophysiology (EP) study and by a bolus injection of atropine and in a step up/down fashion by repeated right atrial ...
Lennart Bergfeldt +5 more
wiley +1 more source
Cardiac arrest due to acquired long QT syndrome during gynecologic laparoscopy: a case report
BackgroundAcquired long QT syndrome (aLQTS) is a disorder of delayed myocardial repolarization induced by medications, electrolyte disturbances, and other factors, with a significantly higher risk in females than in males.
Wenwen Wang +3 more
doaj +1 more source
The compound mutation, a model for acquire long QT syndrome [PDF]
openaire +2 more sources
The Genetics of Acquired Long QT Syndrome
openaire +2 more sources
Acquired Long-QT Syndrome: Mild but Abnormal?
Kashiwa, Asami, Aiba, Takeshi
openaire +3 more sources
QT Prolongation and Acquired Long QT Syndrome in Climbers on Mount Everest
Pilgrim, Thomas +9 more
openaire +2 more sources
Acquired Long QT Syndrome in a Young Patient with Cerebral Contusion
Debasis Panda +6 more
doaj +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Acquired long QT syndrome in hospitalized patients
Heart Rhythm, 2017Acquired long QT syndrome (ALQTS) has long been overlooked in clinical practice. Recent studies reported that severe ALQTS (QTc ≥500 ms) in hospitalized patients is associated with increased all-cause mortality.The purpose of this study was to determine the role of ALQTS in the clinical outcomes of hospitalized patients.Electronic medical records were ...
, , Jie Du
exaly +3 more sources
Pharmacogenomics and acquired long QT syndrome
Pharmacogenomics, 2005During the past decade pharmaceutical companies have been faced with the withdrawal of some of their marketed drugs because of rare, yet lethal, postmarketing reports associated with ventricular arrhythmias. The implicated drugs include antiarrhythmics, but also non-cardiac drugs, such as histamine blockers, antipsychotics, and antibiotics.
Aerssens, J.M.M.R., Paulussen, A.D.
exaly +4 more sources

